Top compounds associated with response to RFWD3


Feature Type Standardized
Nominal ANOVA
mRNA manumycin A CTRPv2 pan-cancer AAC 0.074 0.02
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.076 0.02
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC -0.16 0.03
mRNA pac-1 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA Topotecan CTRPv2 pan-cancer AAC 0.072 0.03
mRNA Doxorubicin gCSI pan-cancer AAC 0.11 0.03
mRNA rigosertib CTRPv2 pan-cancer AAC 0.073 0.03
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.13 0.03
Download CSV